Tirzepatide, the novel medication, is creating considerable interest within the healthcare community. It operates differently from common diabetes medications, targeting multiple receptors involved in blood regulation and satiety. Initial research have demonstrated significant efficacy in lowering blood glucose in individuals with type 2 diabetes a